The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis
Open accessAbstract
BACKGROUND: To investigate small-nucleolar RNAs (snoRNAs) as reference genes when measuring miRNA expression in tumour samples, given emerging evidence for their role in cancer. METHODS: Four snoRNAs, commonly used for normalisation, RNU44, RNU48, RNU43 and RNU6B, and miRNA known to be associated with pathological factors, were measured by real-time polymerase chain reaction in two patient series: 219 breast cancer and 46 head and neck squamous cell carcinoma (HNSCC). SnoRNA and miRNA were then correlated with clinicopathological features and prognosis. RESULTS: Small-nucleolar RNA expression was as variable as miRNA expression (miR-21, miR-210, miR-10b). Normalising miRNA PCR expression data to these recommended snoRNAs introduced bias in associations between miRNA and pathology or outcome. Low snoRNA expression correlated with markers of aggressive pathology. Low levels of RNU44 were associated with a poor prognosis. RNU44 is an intronic gene in a cluster of highly conserved snoRNAs in the growth arrest specific 5 (GAS5) transcript, which is normally upregulated to arrest cell growth under stress. Low-tumour GAS5 expression was associated with a poor prognosis. RNU48 and RNU43 were also identified as intronic snoRNAs within genes that are dysregulated in cancer. CONCLUSION: Small-nucleolar RNAs are important in cancer prognosis, and their use as reference genes can introduce bias when determining miRNA expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,311
Stromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Omeroglu, G., Meterissian, S., Omeroglu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,687
Kino, T., Hurt, D. E., Ichijo, T., Nader, N., & Chrousos, G. P. (2010) · Science Signaling · doi:10.1126/scisignal.2000568 · Cited by 1,231
Yan, L.-X., Huang, X.-F., Shao, Q., Huang, M.-Y., Deng, L., Wu, Q.-L., Zeng, Y.-X., & Shao, J.-Y. (2008) · RNA · doi:10.1261/rna.1034808 · Cited by 1,148
MYC as a regulator of ribosome biogenesis and protein synthesis
van Riggelen, J., Yetil, A., & Felsher, D. W. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2819 · Cited by 956
Wirapati, P., Sotiriou, C., Kunkel, S., Farmer, P., Pradervand, S., Haibe-Kains, B., Desmedt, C., Ignatiadis, M., Sengstag, T., Schütz, F., et al. (2008) · Breast Cancer Research · doi:10.1186/bcr2124 · Cited by 891
Hudis, C. A., Barlow, W. E., Costantino, J. P., Gray, R. J., Pritchard, K. I., Chapman, J.-A. W., Sparano, J. A., Hunsberger, S., Enos, R. A., Gelber, R. D., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.3523 · Cited by 864
Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
Desmedt, C., Haibe-Kains, B., Wirapati, P., Buyse, M., Larsimont, D., Bontempi, G., Delorenzi, M., Piccart, M., & Sotiriou, C. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4756 · Cited by 828
Peltier, H. J., & Latham, G. J. (2008) · RNA · doi:10.1261/rna.939908 · Cited by 820 · cited 1×
“The current convention for miRNA RT–PCR is to normalise to one reference gene (usually RNU6B, RNU44 or RNU48) (Roa et al, 2010).”
BackgroundKiss (2002) · doi:10.1016/s0092-8674(02)00718-3 · Cited by 816
GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer
Mourtada-Maarabouni, M., Pickard, M. R., Hedge, V. L., Farzaneh, F., & Williams, G. T. (2009) · Oncogene · doi:10.1038/onc.2008.373 · Cited by 775
Git, A., Dvinge, H., Salmon-Divon, M., Osborne, M., Kutter, C., Hadfield, J., Bertone, P., & Caldas, C. (2010) · RNA · doi:10.1261/rna.1947110 · Cited by 689
hsa-miR-210 Is Induced by Hypoxia and Is an Independent Prognostic Factor in Breast Cancer
Camps, C., Buffa, F. M., Colella, S., Moore, J., Sotiriou, C., Sheldon, H., Harris, A. L., Gleadle, J. M., & Ragoussis, J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1755 · Cited by 662
Self-citationWelsh, J. B., Zarrinkar, P. P., Sapinoso, L. M., Kern, S. G., Behling, C. A., Monk, B. J., Lockhart, D. J., Burger, R. A., & Hampton, G. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.3.1176 · Cited by 654
Buffa, F. M., Harris, A. L., West, C. M., & Miller, C. J. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605450 · Cited by 556
Self-citationSmall regulatory RNAs in mammals
Mattick, J. S., & Makunin, I. V. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi101 · Cited by 512
Markou, A., Tsaroucha, E. G., Kaklamanis, L., Fotinou, M., Georgoulias, V., & Lianidou, E. S. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.101741 · Cited by 441
Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers
Winter, S. C., Buffa, F. M., Silva, P., Miller, C., Valentine, H. R., Turley, H., Shah, K. A., Cox, G. J., Corbridge, R. J., Homer, J. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3322 · Cited by 410 · cited 2×
“Published metagene signatures were used: to determine molecular classification of subtype (Sorlie et al, 2001); to measure hypoxia (Winter et al, 2007; Buffa et al, 2010); for proliferation, invasion and immune response scores (Desmedt et al, 2008); and for ErBB2 scores (genes in common between…”
MethodSelf-citationComprehensive MicroRNA Profiling for Head and Neck Squamous Cell Carcinomas
Hui, A. B. Y., Lenarduzzi, M., Krushel, T., Waldron, L., Pintilie, M., Shi, W., Perez-Ordonez, B., Jurisica, I., O'Sullivan, B., Waldron, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2166 · Cited by 397
Loi, S., Haibe-Kains, B., Desmedt, C., Wirapati, P., Lallemand, F., Tutt, A. M., Gillet, C., Ellis, P., Ryder, K., Reid, J. F., et al. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-239 · Cited by 389
Breast cancer molecular profiling with single sample predictors: a retrospective analysis
Weigelt, B., Mackay, A., A'hern, R., Natrajan, R., Tan, D. S., Dowsett, M., Ashworth, A., & Reis-Filho, J. S. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70008-5 · Cited by 364
MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
Hummel, R., Hussey, D. J., & Haier, J. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.10.027 · Cited by 344
Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer
Catto, J. W. F., Miah, S., Owen, H. C., Bryant, H., Myers, K., Dudziec, E., Larré, S., Milo, M., Rehman, I., Rosario, D. J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0744 · Cited by 329
Self-citation(2002) · PubMed · Cited by 296
hsa‐miR‐210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer
Gee, H. E., Camps, C., Buffa, F. M., Patiar, S., Winter, S. C., Betts, G., Homer, J., Corbridge, R., Cox, G., West, C. M. L., et al. (2010) · Cancer · doi:10.1002/cncr.25009 · Cited by 248
Self-citationRobust global micro-RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues
Hui, A. B. Y., Shi, W., Boutros, P. C., Miller, N., Pintilie, M., Fyles, T., McCready, D., Wong, D., Gerster, K., Jurisica, I., et al. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.12 · Cited by 232
Chang, K. H., Mestdagh, P., Vandesompele, J., Kerin, M. J., & Miller, N. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-173 · Cited by 225
Implication of snoRNA U50 in human breast cancer
Dong, X.-Y., Guo, P., Boyd, J., Sun, X., Li, Q., Zhou, W., & Dong, J.-T. (2009) · Journal of Genetics and Genomics · doi:10.1016/s1673-8527(08)60134-4 · Cited by 199
Human rRNA Gene Clusters Are Recombinational Hotspots in Cancer
Stults, D. M., Killen, M. W., Williamson, E. P., Hourigan, J. S., Vargas, H. D., Arnold, S. M., Moscow, J. A., & Pierce, A. J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2680 · Cited by 168
MicroRNA-10b and breast cancer metastasis
Gee, H. E., Camps, C., Buffa, F. M., Colella, S., Sheldon, H., Gleadle, J., Ragoussis, J., & Harris, A. L. (2008) · Nature · doi:10.1038/nature07362 · Cited by 149
Self-citationExpression of CPEB, GAPDH and U6snRNA in cervical and ovarian tissue during cancer development
HANSEN, C. N., Ketabi, Z., Rosenstierne, M. W., Palle, C., Boesen, H. C., & Norrild, B. (2009) · Apmis · doi:10.1111/j.1600-0463.2008.00015.x · Cited by 90
Identification of a new microRNA expression profile as a potential cancer screening tool
Roa, W., Brunet, B., Guo, L., Amanie, J., Fairchild, A. M., Gabos, Z., Nijjar, T. S., Scrimger, R. A., Yee, D., & Xing, J. Z. (2010) · Clinical and investigative medicine · doi:10.25011/cim.v33i2.12351 · Cited by 88
Killian, A., Meur, N. L., Sesboüé, R., Bourguignon, J., Bougeard, G., Gautherot, J., Bastard, C., Frébourg, T., & Flaman, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207845 · Cited by 71
Endogenous Controls for Real-Time Quantitation of miRNA Using TaqMan® MicroRNA Assays
Wong, L. (2007) · doi:10.1038/an3515 · Cited by 67
van den Broek, G. B., Wildeman, M. A., Rasch, C. R. N., Armstrong, N. J., Schuuring, E. M. D., Begg, A. C., Looijenga, L. H. J., Scheper, R. J., van der Wal, J. E., Menkema, L., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24254 · Cited by 60
Breast pathology: beyond morphology
Simpson, P. T., Reis-Filho, J. S., & Lakhani, S. R. (2010) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2009.12.001 · Cited by 16
Cited by
Sloan, K. E., Warda, A. S., Sharma, S., Entian, K.-D., Lafontaine, D. L. J., & Bohnsack, M. T. (2017) · RNA Biology · doi:10.1080/15476286.2016.1259781 · Cited by 707
Data Normalization Strategies for MicroRNA Quantification
Schwarzenbach, H., da Silva, A. M., Calin, G., & Pantel, K. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.239459 · Cited by 468
Are snoRNAs and snoRNA host genes new players in cancer?
Williams, G. T., & Farzaneh, F. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3195 · Cited by 362
Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines
Pickard, M. R., Mourtada-Maarabouni, M., & Williams, G. T. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.005 · Cited by 331
Non-coding RNAs and potential therapeutic targeting in cancer
Toden, S., Zumwalt, T. J., & Goel, A. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188491 · Cited by 327
Metadata
- Authors
- Gee, H. E., Buffa, F. M., Camps, C., Ramachandran, A., Leek, R., Taylor, M., Patil, M., Sheldon, H., Betts, G., Homer, J., West, C., Ragoussis, J., & Harris, A. L.
- Venue
- British Journal of Cancer
- Published
- 2011-03
- Volume
- 104
- Issue
- 7
- Pages
- 1168-1177
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2081339873
- Cited by
- 283
- References
- 38
- FWCI
- 7.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.